Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Insulin_lispro> ?p ?o }
- Insulin_lispro abstract "Insulin lispro (marketed by Eli Lilly and Company as \"Humalog\") is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market.Engineered through recombinant DNA technology, the penultimate lysine and proline residues on the C-terminal end of the B-chain are reversed. This modification does not alter receptor binding, but blocks the formation of insulin dimers and hexamers. This allowed larger amounts of active monomeric insulin to be immediately available for postprandial injections.Insulin lispro has one primary advantage over regular insulin for postprandial glucose control. It has a shortened delay of onset, allowing slightly more flexibility than regular insulin, which requires a longer waiting period before starting a meal after injection. Both preparations should be coupled with a longer acting insulin (e.g. Insulin degludec) for good glycemic control.".
- Insulin_lispro atcPrefix "A10".
- Insulin_lispro atcSuffix "AB04".
- Insulin_lispro casNumber "133107-64-9".
- Insulin_lispro drugbank "DB00046".
- Insulin_lispro fdaUniiCode "GFX7QIS1II".
- Insulin_lispro pubchem "16132438".
- Insulin_lispro wikiPageExternalLink ucm200845.htm.
- Insulin_lispro wikiPageID "12923152".
- Insulin_lispro wikiPageLength "4197".
- Insulin_lispro wikiPageOutDegree "31".
- Insulin_lispro wikiPageRevisionID "691441101".
- Insulin_lispro wikiPageWikiLink Anaphylaxis.
- Insulin_lispro wikiPageWikiLink Cardiovascular_disease.
- Insulin_lispro wikiPageWikiLink Category:Diabetes.
- Insulin_lispro wikiPageWikiLink Category:Eli_Lilly_and_Company.
- Insulin_lispro wikiPageWikiLink Category:Human_proteins.
- Insulin_lispro wikiPageWikiLink Category:Insulin_therapies.
- Insulin_lispro wikiPageWikiLink Category:Peptide_hormones.
- Insulin_lispro wikiPageWikiLink Category:Recombinant_proteins.
- Insulin_lispro wikiPageWikiLink Diabetes_mellitus_type_1.
- Insulin_lispro wikiPageWikiLink Diabetes_mellitus_type_2.
- Insulin_lispro wikiPageWikiLink Diabetic_nephropathy.
- Insulin_lispro wikiPageWikiLink Diabetic_neuropathy.
- Insulin_lispro wikiPageWikiLink Eli_Lilly_and_Company.
- Insulin_lispro wikiPageWikiLink Excipient.
- Insulin_lispro wikiPageWikiLink Food_and_Drug_Administration.
- Insulin_lispro wikiPageWikiLink Hypersensitivity.
- Insulin_lispro wikiPageWikiLink Hypoglycemia.
- Insulin_lispro wikiPageWikiLink Hypokalemia.
- Insulin_lispro wikiPageWikiLink Injection_(medicine).
- Insulin_lispro wikiPageWikiLink Injection_site_reaction.
- Insulin_lispro wikiPageWikiLink Insulin_analog.
- Insulin_lispro wikiPageWikiLink Insulin_degludec.
- Insulin_lispro wikiPageWikiLink Lipodystrophy.
- Insulin_lispro wikiPageWikiLink Longer_acting_insulin.
- Insulin_lispro wikiPageWikiLink Lysine.
- Insulin_lispro wikiPageWikiLink Postprandial.
- Insulin_lispro wikiPageWikiLink Proline.
- Insulin_lispro wikiPageWikiLink Protein_dimer.
- Insulin_lispro wikiPageWikiLink Recombinant_DNA.
- Insulin_lispro wikiPageWikiLink Side_effect.
- Insulin_lispro wikiPageWikiLinkText "Humalog".
- Insulin_lispro wikiPageWikiLinkText "Insulin lispro".
- Insulin_lispro wikiPageWikiLinkText "insulin lispro".
- Insulin_lispro wikiPageWikiLinkText "lispro".
- Insulin_lispro atcPrefix "A10".
- Insulin_lispro atcSuffix "AB04".
- Insulin_lispro c "257".
- Insulin_lispro casNumber "133107".
- Insulin_lispro chemspiderid "none".
- Insulin_lispro drugbank "DB00046".
- Insulin_lispro h "389".
- Insulin_lispro kegg "D04477".
- Insulin_lispro legalUk "POM".
- Insulin_lispro legalUs "Rx-only".
- Insulin_lispro medlineplus "a697021".
- Insulin_lispro molecularWeight "5813.63".
- Insulin_lispro n "65".
- Insulin_lispro o "77".
- Insulin_lispro pregnancyUs "C".
- Insulin_lispro pubchem "16132438".
- Insulin_lispro routesOfAdministration "Subcutaneous".
- Insulin_lispro s "6".
- Insulin_lispro unii "GFX7QIS1II".
- Insulin_lispro verifiedfields "changed".
- Insulin_lispro verifiedrevid "458271570".
- Insulin_lispro wikiPageUsesTemplate Template:Cascite.
- Insulin_lispro wikiPageUsesTemplate Template:Chemspidercite.
- Insulin_lispro wikiPageUsesTemplate Template:Drugbankcite.
- Insulin_lispro wikiPageUsesTemplate Template:Drugbox.
- Insulin_lispro wikiPageUsesTemplate Template:Drugs.com.
- Insulin_lispro wikiPageUsesTemplate Template:Fdacite.
- Insulin_lispro wikiPageUsesTemplate Template:Keggcite.
- Insulin_lispro wikiPageUsesTemplate Template:Oral_hypoglycemics_and_insulin_analogs.
- Insulin_lispro wikiPageUsesTemplate Template:Peptidergics.
- Insulin_lispro subject Category:Diabetes.
- Insulin_lispro subject Category:Eli_Lilly_and_Company.
- Insulin_lispro subject Category:Human_proteins.
- Insulin_lispro subject Category:Insulin_therapies.
- Insulin_lispro subject Category:Peptide_hormones.
- Insulin_lispro subject Category:Recombinant_proteins.
- Insulin_lispro type ChemicalSubstance.
- Insulin_lispro type Company.
- Insulin_lispro type Drug.
- Insulin_lispro type Chemical.
- Insulin_lispro type Company.
- Insulin_lispro type Diabete.
- Insulin_lispro type Drug.
- Insulin_lispro type Hormone.
- Insulin_lispro type Peptide.
- Insulin_lispro type Product.
- Insulin_lispro type Redirect.
- Insulin_lispro type ChemicalObject.
- Insulin_lispro type Thing.
- Insulin_lispro type Q8386.
- Insulin_lispro comment "Insulin lispro (marketed by Eli Lilly and Company as \"Humalog\") is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market.Engineered through recombinant DNA technology, the penultimate lysine and proline residues on the C-terminal end of the B-chain are reversed. This modification does not alter receptor binding, but blocks the formation of insulin dimers and hexamers.".
- Insulin_lispro label "Insulin lispro".
- Insulin_lispro sameAs Q3492616.
- Insulin_lispro sameAs الأنسولين_ليسبرو.